MELAS
From Ganfyd
Web Resources for MELAS
ICD 10 code: G71.3
Relevant Clinical Literature
RCT with MELAS from Pubmed
UK Guidance
Other Wikis
Medpedia on MELAS (Less technical, good quality control)
Wikipedia on MELAS (Less technical, ? quality control)
See mitochondrial diseases for more details of the context of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes a mitochondrial disorder with usual onset (in 90%) before 40 years. It is associated with seizures, headaches, vomiting attacks and diabetes mellitus. It results in dementia. Normal lactate and/or pyruvate levels effectively exclude it, although there are reports of variable penetrance, and raised CSF lactate is more specific at the time of stroke like episodes.
Aetiology
Multiple point mutations can cause it in the MT-TL1 (TRNL1, MTTL1, tRNALeu(UUR), mitochondrially encoded tRNA leucine 1 (UUA/G)) , MT-TQ (TRNQ, MTTQ, tRNAGlu mitochondrially encoded tRNA glutamine), MT-TH (TRNH, MTTH, tRNAHis, mitochondrially encoded tRNA histidine), MT-TK (TRNK, MTTK, tRNALys, mitochondrially encoded tRNA lysine), MT-TS1 (TRNS1, MTTS1, tRNASer mitochondrially encoded tRNA serine 1 (UCN)), MT-ND1 (MTND1, mitochondrially encoded NADH dehydrogenase 1), MT-ND5 (ND5, MTND5, mitochondrially encoded NADH dehydrogenase 5), MT-COI (COX1, mitochondrially encoded cytochrome c oxidase I)[1] or MT-ND6 (ND6, mitochondrially encoded NADH dehydrogenase 6) genes. The most common mutation is A3243G in the MT-TL1 gene[2].Treatment
There is no proven treatment. In particular dichloroacetate (DCA) has been shown in two trials to cause in due course neuropathic symptoms that appear to outweigh any benefit. The status of arginine and coenzyme Q10 are unknown[3].
References
- ↑ Tam EW, Feigenbaum A, Addis JB, Blaser S, Mackay N, Al-Dosary M, Taylor RW, Ackerley C, Cameron JM, Robinson BH. A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics. 2008 Dec; 39(6):328-34.(Link to article – subscription may be required.)
- ↑ Lorenzoni PJ, Scola RH, Kay CS, Arndt RC, Freund AA, Bruck I, Santos ML, Werneck LC. MELAS: clinical features, muscle biopsy and molecular genetics. Arquivos de neuro-psiquiatria. 2009 Sep; 67(3A):668-76.
- ↑ Kerr DS. Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade. Molecular genetics and metabolism. 2009 Nov 26.(Epub ahead of print) (Link to article – subscription may be required.)

